Osaka, Japan

Kenji Yano

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Anges Mg, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Yano. Retrieved from https://idiyas.com/inventor/kenji-yano-ovfk3boa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenji Yano: Innovator in Tissue Survival Enhancement

Introduction

Kenji Yano is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of tissue survival through his innovative research and patents. His work focuses on enhancing the survival of organ transplants and skin grafts, which has important implications for medical science.

Latest Patents

Kenji Yano holds a patent for a groundbreaking invention titled "Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survival." This patent relates to the use of growth factors to improve tissue survival. Specifically, it describes methods for enhancing the survival of organ transplants, musculocutaneous flaps, or skin grafts by administering a nucleic acid sequence encoding hepatocyte growth factor. He has 1 patent to his name.

Career Highlights

Throughout his career, Kenji Yano has been associated with Anges Mg, Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of tissue survival mechanisms, which is crucial for improving surgical outcomes.

Collaborations

Kenji has collaborated with notable colleagues, including Tateki Kubo and Marvin A Tanag. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kenji Yano's contributions to the field of tissue survival enhancement through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…